Literature DB >> 19074141

alpha2-Macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species.

Justin J Yerbury1, Janet R Kumita, Sarah Meehan, Christopher M Dobson, Mark R Wilson.   

Abstract

alpha(2)-Macroglobulin (alpha(2)M) and haptoglobin (Hp) are both abundant secreted glycoproteins that are best known for their protease trapping and hemoglobin binding activities, respectively. Like the small heat shock proteins, both these glycoproteins have in common the ability to protect a range of proteins from stress-induced amorphous aggregation and have been described as extracellular chaperones. Using an array of biophysical techniques, this study establishes that in vitro at substoichiometric levels and under physiological conditions alpha(2)M and Hp both inhibit the formation of amyloid fibrils from a range of proteins. We also provide evidence that both alpha(2)M and Hp interact with prefibrillar species to maintain the solubility of amyloidogenic proteins. These findings suggest that both alpha(2)M and Hp are likely to play an important role in controlling the inappropriate aggregation of proteins in the extracellular environment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074141     DOI: 10.1074/jbc.M807242200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands.

Authors:  Thomas E Finn; Andrea C Nunez; Margaret Sunde; Simon B Easterbrook-Smith
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

2.  A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis.

Authors:  Christine L Hagan; Russell J K Johnson; Anne Dhulesia; Mireille Dumoulin; Janice Dumont; Erwin De Genst; John Christodoulou; Carol V Robinson; Christopher M Dobson; Janet R Kumita
Journal:  Protein Eng Des Sel       Date:  2010-04-09       Impact factor: 1.650

Review 3.  Specific chaperones and regulatory domains in control of amyloid formation.

Authors:  Michael Landreh; Anna Rising; Jenny Presto; Hans Jörnvall; Jan Johansson
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

4.  Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects.

Authors:  Steven P Millard; Franziska Lutz; Ge Li; Douglas R Galasko; Martin R Farlow; Joseph F Quinn; Jeffrey A Kaye; James B Leverenz; Debby Tsuang; Chang-En Yu; Elaine R Peskind; Lynn M Bekris
Journal:  Neurobiol Aging       Date:  2013-09-04       Impact factor: 4.673

5.  Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.

Authors:  Patrick Constantinescu; Rebecca A Brown; Amy R Wyatt; Marie Ranson; Mark R Wilson
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

6.  BRICHOS domains efficiently delay fibrillation of amyloid β-peptide.

Authors:  Hanna Willander; Jenny Presto; Glareh Askarieh; Henrik Biverstål; Birgitta Frohm; Stefan D Knight; Jan Johansson; Sara Linse
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

7.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

8.  Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line.

Authors:  Bernardetta Maresca; Maria Stefania Spagnuolo; Luisa Cigliano
Journal:  J Mol Neurosci       Date:  2014-11-18       Impact factor: 3.444

9.  Unraveling the genes implicated in Alzheimer's disease.

Authors:  Mohan Giri; Abhilasha Shah; Bibhuti Upreti; Jayanti Chamling Rai
Journal:  Biomed Rep       Date:  2017-06-14

10.  Structural characterization of clusterin-chaperone client protein complexes.

Authors:  Amy R Wyatt; Justin J Yerbury; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.